EOCN · Eocene Ltd.
AI read · Good for EOCN
The AI's read
This gives Eocene a possible new way to direct Aramchol toward tumors. The report says the work may support the drug's effects, but it gives no patient results or proof of benefit. That makes this a favorable research step, not a proven treatment advance.